News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biocorrx Inc. Announces Expansion Of The Start Fresh Program To Include Treatment Of Opioid Dependence


3/4/2014 9:04:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Los Angeles, March 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx Inc. ('the Company") (OTCQB: BICX) is pleased to announce the expansion of their revolutionary Start Fresh Program. In light of an escalating problem to society, as well as patient demand the Company is opening up the program to treat opioid addiction. The abuse of prescription painkillers burdens the U.S. healthcare system with an estimated annual cost of $72 billion, and according to the Centers for Disease Control prescription drug overdose deaths have more than quadrupled since 1999. While actual statistics on drug abuse are difficult to compile, CDC estimates that for every one death there are 825 non-medical users of prescription painkillers. "Expanding our cutting-edge treatment program to help individuals addicted to painkillers is a natural next step for us and we feel confident about grasping a piece of the estimated $1 billion in annual revenue generated by this market" said Kent Emry, CEO of BioCorRx.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
 
 
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES